Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database.
David AlfegoJennifer EnnisBarbara GillespieMary Jane LewisElizabeth MontgomerySilvia FerrèJoseph A VassalottiStanley LetovskyPublished in: Diabetes care (2021)
Despite guideline recommendations, testing for CKD with uACR and eGFR in U.S. adults with diabetes and hypertension is low in routine clinical care. These data highlight the need for strategies to improve routine CKD assessment nationwide.
Keyphrases
- chronic kidney disease
- end stage renal disease
- clinical practice
- quality improvement
- small cell lung cancer
- blood pressure
- type diabetes
- healthcare
- cardiovascular disease
- epidermal growth factor receptor
- tyrosine kinase
- glycemic control
- metabolic syndrome
- emergency department
- weight loss
- chronic pain
- skeletal muscle
- affordable care act
- health insurance
- arterial hypertension